TET2 and glioblastoma: In humans, intragenic CpG sites within TET2 showed higher levels of 5-mC and lower levels of 5-hmC in GBM compared to normal brain, although within the TET2 promoter low levels of both 5-mC and 5-hmC were detected at CpG sites of normal brain and GBM (63).